M2A-MAGNUM 52-60MM TPR INSRT-3
Report
- Report Number
- 0001825034-2022-00598
- Event Type
- Injury
- Date Received
- March 23, 2022
- Date of Event
- November 17, 2020
- Report Date
- May 4, 2022
- Manufacturer
- ZIMMER BIOMET, INC.
- Product Code
- KWY
- PMA / PMN Number
- K101336
- Removal / Correction Number
- N/A
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
(B)(4). CONCOMITANT MEDICAL PRODUCTS: CATALOG NUMBER:139266 LOT NUMBER:961790 BRAND NAME: M2A MAGNUM TPR INSRT. CATALOG NUMBER:157456 LOT NUMBER: 814560 BRAND NAME: M2A MAGNUM HEAD. CATALOG NUMBER:US157862 LOT NUMBER:315260 BRAND NAME: M2A-MAGNUM PF CUP. CATALOG NUMBER:192411 LOT NUMBER:219480 BRAND NAME: ECHO POR FMRL RED NC. MULTIPLE REPORTS WERE SUBMITTED ALONG WITH THIS REPORT : 0001825034-2022-00598 AND 0001825034-2022-00599. THE INVESTIGATION IS IN PROCESS. ONCE THE INVESTIGATION HAS BEEN COMPLETED, A FOLLOW-UP MDR WILL BE SUBMITTED.
UPON RECEIPT OF ADDITIONAL INFORMATION IT HAS BEEN DETERMINED THAT THE REPORTED DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE EVENT. INITIAL REPORT SHOULD BE VOIDED.
IT WAS REPORTED THAT THE PATIENT WAS REVISED DUE TO ELEVATED METAL IONS AND ADVERSE LOCAL TISSUE REACTION APPROXIMATELY 9 YEARS POST IMPLANTATION. DURING THE REVISION THERE WAS NO SIGNIFICANT METAL DEBRIS OR STAINING, MINIMAL TISSUE NECROSIS, AND WEAKENED POSTERIOR CAPSULE. THE HEAD AND TAPER ADAPTER WERE EXCHANGED WITHOUT COMPLICATION'S. ATTEMPTS HAVE BEEN MADE AND ADDITIONAL INFORMATION ON THE REPORTED EVENT IS UNAVAILABLE AT THIS TIME.
UPON RECEIPT OF ADDITIONAL INFORMATION IT HAS BEEN DETERMINED THAT THE REPORTED DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 715405 | M2A-MAGNUM 52-60MM TPR INSRT-3 | PROSTHESIS, HIP | KWY | ZIMMER BIOMET, INC. | N/A | 961790 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Male | Hospitalization| R |